TP53 and head and neck squamous cell carcinoma: In HNSCC, understanding the molecular pathways and predicting patient outcomes is greatly aided by the use of various IHC markers, especially in the context of HPV infection. Salazar et al. (2014) and Smith et al. (2010) have identified p53 as important markers associated with survival in HNSCC [9,10].